tiprankstipranks
Advertisement
Advertisement

JP:4569 Stock Latest News

KYORIN Licenses BIODOL’s Novel Neuropathic Pain Drug for Key Asian Markets
Company AnnouncementsKYORIN Licenses BIODOL’s Novel Neuropathic Pain Drug for Key Asian Markets
9d ago
4569
KYORIN Secures Exclusive Japan Rights to Promote and Distribute J&J’s SIRTURO
PremiumCompany Announcements
KYORIN Secures Exclusive Japan Rights to Promote and Distribute J&J’s SIRTURO
15d ago
4569
Kyorin Pharma Overhauls Governance With New Mandate-Based Officer System
PremiumCompany Announcements
Kyorin Pharma Overhauls Governance With New Mandate-Based Officer System
1M ago
4569
KYORIN Wins Approval for Faster, More Sensitive GeneSoC FluA/B Influenza Test Kit
PremiumCompany Announcements
KYORIN Wins Approval for Faster, More Sensitive GeneSoC FluA/B Influenza Test Kit
2M ago
4569
KYORIN Pharma Releases Nine-Month Consolidated Results and Outlook
PremiumCompany Announcements
KYORIN Pharma Releases Nine-Month Consolidated Results and Outlook
2M ago
4569
KYORIN Pharmaceutical Lifts Nine-Month Profit but Keeps Lower Full-Year Outlook
PremiumCompany AnnouncementsKYORIN Pharmaceutical Lifts Nine-Month Profit but Keeps Lower Full-Year Outlook
2M ago
4569
KYORIN Taps Lunatus to Launch Antibacterial Drug Lasvic Across Middle East
Premium
Company Announcements
KYORIN Taps Lunatus to Launch Antibacterial Drug Lasvic Across Middle East
3M ago
4569
KYORIN Pharmaceutical Reports Mixed Financial Results for H1 2025
Premium
Company Announcements
KYORIN Pharmaceutical Reports Mixed Financial Results for H1 2025
5M ago
4569
KYORIN Partners with Hinge Bio for SLE Drug Development in Japan
PremiumCompany Announcements
KYORIN Partners with Hinge Bio for SLE Drug Development in Japan
6M ago
4569
KYORIN Pharma Announces Phase 3 Study Results for Pulmonary Sarcoidosis Treatment
PremiumCompany Announcements
KYORIN Pharma Announces Phase 3 Study Results for Pulmonary Sarcoidosis Treatment
7M ago
4569
KYORIN Pharmaceutical Reports Strong Quarterly Growth Amidst Challenging Full-Year Outlook
PremiumCompany Announcements
KYORIN Pharmaceutical Reports Strong Quarterly Growth Amidst Challenging Full-Year Outlook
8M ago
4569
KYORIN Pharmaceutical Announces Dividend Distribution
PremiumCompany Announcements
KYORIN Pharmaceutical Announces Dividend Distribution
11M ago
4569
KYORIN Pharmaceutical Announces Executive Personnel Changes
PremiumCompany AnnouncementsKYORIN Pharmaceutical Announces Executive Personnel Changes
11M ago
4569
KYORIN Pharmaceutical to Cancel 7.2% of Treasury Shares to Boost Capital Efficiency
Premium
Company Announcements
KYORIN Pharmaceutical to Cancel 7.2% of Treasury Shares to Boost Capital Efficiency
11M ago
4569
KYORIN Pharmaceutical Announces Special Dividend Amid Profit Surge
Premium
Company Announcements
KYORIN Pharmaceutical Announces Special Dividend Amid Profit Surge
11M ago
4569
KYORIN Pharmaceutical Reports Strong Financial Growth Amidst Upcoming Challenges
PremiumCompany Announcements
KYORIN Pharmaceutical Reports Strong Financial Growth Amidst Upcoming Challenges
11M ago
4569
KYORIN Pharmaceutical Upgrades Earnings Forecasts Following Licensing Deals
PremiumCompany Announcements
KYORIN Pharmaceutical Upgrades Earnings Forecasts Following Licensing Deals
12M ago
4569
KYORIN and Novartis Forge Global License Agreement for KRP-M223
PremiumCompany Announcements
KYORIN and Novartis Forge Global License Agreement for KRP-M223
1y ago
4569
KYORIN Partners with Hyfe for AI-Powered Chronic Cough Therapy
PremiumCompany Announcements
KYORIN Partners with Hyfe for AI-Powered Chronic Cough Therapy
1y ago
4569
KYORIN Pharmaceutical Secures Option for Novel Post-Viral Hyposmia Treatment
PremiumCompany AnnouncementsKYORIN Pharmaceutical Secures Option for Novel Post-Viral Hyposmia Treatment
1y ago
4569
KYORIN Pharmaceutical Reports Decline in Nine-Month Financial Performance
Premium
Company Announcements
KYORIN Pharmaceutical Reports Decline in Nine-Month Financial Performance
1y ago
4569
KYORIN Enters Agreement with BIODOL for Novel Pain Treatment
Premium
Company Announcements
KYORIN Enters Agreement with BIODOL for Novel Pain Treatment
1y ago
4569

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >